soul trial oral semaglutide cardiovascular outcomes results 2025 nejm found to lower risk of heart failure events in people with type 2 diabetes Cardiovascular Outcomes Associated with Semaglutide

For people on GLP-1 medications, soluble prebiotic fiber is generally considered gentler than insoluble fiber, particularly during periods of slower gastric motility

New Patient Pricing and package or series pricing are separate offers calculated from the standard price and cannot be combined

Both drugs offer impressive results for weight loss and metabolic health benefits, but their high cost often makes access a challenge

Immunity 54 , 15781593.e5 (2021)

It mimics the effects of the hormone glucagon-like peptide-1 (GLP-1), which can help lower blood sugar by causing insulin to release, leading to slower digestion